-
- TANAKA Yasushi
- Research Center for Pathogenic Fungi and Microbial Toxicoses, Chiba University
-
- YAZAWA Katsukiyo
- Research Center for Pathogenic Fungi and Microbial Toxicoses, Chiba University
-
- DABBS Eric R
- Research Center for Pathogenic Fungi and Microbial Toxicoses, Chiba University
-
- NISHIKAWA Kazutaka
- Research Center for Pathogenic Fungi and Microbial Toxicoses, Chiba University
-
- KOMAKI Hisayuki
- Research Center for Pathogenic Fungi and Microbial Toxicoses, Chiba University
-
- MIKAMI Yuzuru
- Research Center for Pathogenic Fungi and Microbial Toxicoses, Chiba University
-
- MIYAJI Makoto
- Research Center for Pathogenic Fungi and Microbial Toxicoses, Chiba University
-
- MORISAKI Naoko
- Institute of Molecular and Cellular Bioscience, The University of Tokyo
-
- IWASAKI Shigeo
- Institute of Molecular and Cellular Bioscience, The University of Tokyo
この論文をさがす
抄録
Mycolic acid-containing bacteria inactivate rifampicin in a variety of ways such as glucosylation, ribosylation, phosphorylation and decolorization. These inactivations were found to be a species-specific phenomena in Nocardia and related taxa. Gordona, Tsukamurella and fast-growing Mycobacterium modified rifampicin by ribosylation of the 23-OH group of the antibiotic. Such ribosylation was not observed in Rhodococcus and Corynebacterium, but phosphorylation of the 21-OH group of rifampicin was observed in one strain of Rhodococcus. Nocardia modified the antibiotic by glucosylation (23-OH group) and phosphorylation, but ribosylation was not observed.
収録刊行物
-
- Microbiology and immunology
-
Microbiology and immunology 40 (1), 1-4, 1996-01-20
財団法人 学会誌刊行センター
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1571980074132140672
-
- NII論文ID
- 10004786667
-
- NII書誌ID
- AA00738350
-
- ISSN
- 03855600
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles